Cite
HARVARD Citation
Nakashima, K. et al. (2023). An 83‐year‐old patient with RET fusion‐positive non‐small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration. Respirology case reports. 11 (5), p. n/a. [Online].